Yes that first major contract was always going to be the hardest. If people wish to sell because they are worried about the US stock market, or worried that the FDA hasn't approved Painchek yet, they are free to sell their shares and then life goes on. Chances are that the buyer has a better idea of the story than the seller. Phil Daffas has barely been working here one year full-time, if that puts some things in perspective.
EPAT General Discussion, page-1045
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
